ConductScience.org, home

Paper11222697

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

York J and 5 others. J Virol, 2001. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. Papers, record 11222697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11222697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.
PubMed
Journal
J Virol
PubMed
Year
2001
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1
iCite
Revised in PubMed
2025-09-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1York JJ
2Follis KEK E
3Trahey MM
4Nyambi PNP N
5Zolla-Pazner SS
6Nunberg JHJ H

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
HIV AntibodiesMajor topic
HIV InfectionsMajor topic
HIV-1Major topic
Antibody Affinity
Cell Line
Flow Cytometry
Gene Products, env
Humans
Neutralization Tests
T-Lymphocytes
Transfection
Virion

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI44312NIAID NIH HHSUnited StatesR21AI044312PubMed and NIHNIH RePORTER
R01 AI036085NIAID NIH HHSUnited StatesR01AI036085PubMed and NIHNIH RePORTER
AI32424NIAID NIH HHSUnited StatesR01AI032424PubMed and NIHNIH RePORTER
AI36085NIAID NIH HHSUnited StatesR01AI036085PubMed and NIHNIH RePORTER
AI44669NIAID NIH HHSUnited StatesR01AI044669PubMed and NIHNIH RePORTER
R01 HL059725NHLBI NIH HHSUnited StatesR01HL059725PubMed and NIHNIH RePORTER
HL59725NHLBI NIH HHSUnited StatesR01HL059725PubMed and NIHNIH RePORTER

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18709238Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.J Virol1996https://conductscience.org/library/papers/8709238PubMed
22564898Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.J Virol1989https://conductscience.org/library/papers/2564898PubMed
39814710Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.Cell1998https://conductscience.org/library/papers/9814710PubMed
42018048Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4.Am J Med1991https://conductscience.org/library/papers/2018048PubMed
59888845RETRACTED: Fusion-competent vaccines: broad neutralization of primary isolates of HIV.Science1999https://conductscience.org/library/papers/9888845PubMed
68347397
Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.
AIDS Res Hum Retroviruses1993https://conductscience.org/library/papers/8347397PubMed
79499111Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity.J Virol1998https://conductscience.org/library/papers/9499111PubMed
87693970Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.J Virol1993https://conductscience.org/library/papers/7693970PubMed
97786580Increase in sensitivity to soluble CD4 by primary HIV type 1 isolates after passage through C8166 cells: association with sequence differences in the first constant (C1) region of glycoprotein 120.AIDS Res Hum Retroviruses1995https://conductscience.org/library/papers/7786580PubMed
102002552Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.J Virol1991https://conductscience.org/library/papers/2002552PubMed
119400598Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.Virology1997https://conductscience.org/library/papers/9400598PubMed
1210888925Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection.Nat Med2000https://conductscience.org/library/papers/10888925PubMed
138819579HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.AIDS1995https://conductscience.org/library/papers/8819579PubMed
149499039Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.J Virol1998https://conductscience.org/library/papers/9499039PubMed
152395859High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2395859PubMed
167692082A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.J Virol1993https://conductscience.org/library/papers/7692082PubMed
172974157Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2974157PubMed
189764911Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.AIDS Res Hum Retroviruses1998https://conductscience.org/library/papers/9764911PubMed
198312057Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.AIDS Res Hum Retroviruses1993https://conductscience.org/library/papers/8312057PubMed
207685962Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.Virology1993https://conductscience.org/library/papers/7685962PubMed

See all 68 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
41648506Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques.bioRxiv2026https://conductscience.org/library/papers/41648506PubMed
38289101Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.J Virol2024https://conductscience.org/library/papers/38289101PubMed
35770989Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14+ Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines.J Virol2022https://conductscience.org/library/papers/35770989PubMed
34549974Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.J Virol2021https://conductscience.org/library/papers/34549974PubMed
33148792Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.J Virol2021https://conductscience.org/library/papers/33148792PubMed
29618643Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.J Virol2018https://conductscience.org/library/papers/29618643PubMed
26113642HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein.Science2015https://conductscience.org/library/papers/26113642PubMed
26018167
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
J Virol2015https://conductscience.org/library/papers/26018167PubMed
24884925Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers.Retrovirology2014https://conductscience.org/library/papers/24884925PubMed
19574645Production, purification, crystallization and preliminary X-ray diffraction analysis of the HIV-2-neutralizing V3 loop-specific Fab fragment 7C8.Acta Crystallogr Sect F Struct Biol Cryst Commun2009https://conductscience.org/library/papers/19574645PubMed
18822440Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity.Virology2008https://conductscience.org/library/papers/18822440PubMed
18031785N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.Virology2008https://conductscience.org/library/papers/18031785PubMed
16956933Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization.J Virol2006https://conductscience.org/library/papers/16956933PubMed
16699036
Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.
J Virol2006https://conductscience.org/library/papers/16699036PubMed
16140761Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.J Virol2005https://conductscience.org/library/papers/16140761PubMed
15994775Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.J Virol2005https://conductscience.org/library/papers/15994775PubMed
14607875Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.Clin Diagn Lab Immunol2003https://conductscience.org/library/papers/14607875PubMed
12857927Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.J Virol2003https://conductscience.org/library/papers/12857927PubMed
12502824Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site.J Virol2003https://conductscience.org/library/papers/12502824PubMed
12477867Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.J Virol2003https://conductscience.org/library/papers/12477867PubMed

See all 31 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ERVK-664006PubTator's text mininghttps://conductscience.org/library/genes/64006NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11222697

GET https://conductscience.org/api/papers/v1/11222697/references?page=2